Tanja Dudenbostel | Endocrinology | Research Excellence Award

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Research Excellence Award

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Assistant Professor at University of Alabama at Birmingham | United States

Endocrinology expert Assoc. Prof. Dr. Tanja Dudenbostel is an accomplished Assistant Professor at the University of Alabama at Birmingham, United States, widely recognized for her impactful contributions to endocrine and metabolic research. Assoc. Prof. Dr. Tanja Dudenbostel completed advanced medical and academic training in endocrinology-related disciplines, forming a strong foundation for translational and clinical research. Professionally, Assoc. Prof. Dr. Tanja Dudenbostel is actively engaged in academic teaching, clinical investigation, and high-impact scientific publishing. Her research interests focus on hormonal regulation, metabolic disorders, cardiometabolic risk, and endocrine mechanisms underlying chronic diseases. Her research skills include clinical research design, data analysis, biomarker evaluation, and evidence-based endocrinology. With more than two thousand citations, an h-index of 25, and a strong i10-index, Assoc. Prof. Dr. Tanja Dudenbostel has earned notable academic recognition. In conclusion, Assoc. Prof. Dr. Tanja Dudenbostel is a leading Endocrinology scholar whose research excellence continues to advance clinical understanding and patient-centered endocrine care.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

.

Citations
2285
i10index
25

h-index
36

🟦 Citations 🟥 Documents 🟩 h-index

View Google Scholar Profile

Featured Publications

Refractory hypertension: definition, prevalence, and patient characteristics
– The Journal of Clinical Hypertension, 2012
Resistant hypertension, obstructive sleep apnoea and aldosterone
– Journal of Human Hypertension, 2012
Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure
– Hypertension, 2015
Effects of antihypertensive drugs on arterial stiffness
– Cardiology in Review, 2012
Refractory hypertension: a novel phenotype of antihypertensive treatment failure
– Hypertension, 2016
Prevalence and clinical characteristics of refractory hypertension
– Journal of the American Heart Association, 2017
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease
– Journal of Human Hypertension, 2012

ÜMMÜGÜLSÜM CAN | Endocrine | Best Researcher Award

Prof. ÜMMÜGÜLSÜM CAN | Endocrine | Best Researcher Award

Medical Doctor | Konya City Center | Turkey

Based on the information provided, Prof. MD. Ümmügülsüm Can appears to be a highly qualified candidate for the Research for Best Researcher Award. Here’s why:

Reasons for Suitability:

  1. Extensive Research Contributions: Prof. Can has a substantial number of published articles in prominent SCI, SCI Expanded, and other internationally recognized journals. Her research covers a broad spectrum of topics, including oxidative stress, metabolic syndrome, diabetes, cardiovascular diseases, and biomarkers in various health conditions. This extensive publication record demonstrates a significant contribution to the field of biochemistry and related medical research.
  2. High Impact Publications: Her work has been cited numerous times across different studies, indicating that her research has had a meaningful impact on the field. For example, articles such as the one on “Leukocyte lipid peroxidation” and “The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease” are highly cited, underscoring the relevance and influence of her work.
  3. Diverse Research Interests: Prof. Can’s research interests are diverse, spanning from lipid peroxidation and antioxidative defense systems to novel biomarkers for diseases like diabetes, obesity, and cardiovascular conditions. This diversity highlights her adaptability and expertise in addressing various critical health issues through her research.
  4. International Recognition: Her involvement in international conferences and collaborations, such as those with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the FEBS Congress, showcases her active engagement with the global research community.
  5. Book Contributions: Authoring book chapters on topics like inflammatory biomarkers and lung diseases further reflects her commitment to advancing knowledge in her field.
  6. Educational Background and Board Certifications: Prof. Can’s solid educational background, including her doctorate and certifications, supports her deep expertise in biochemistry and research.

Given these points, Prof. MD. Ümmügülsüm Can’s extensive research contributions, high-impact publications, diverse research interests, and international recognition make her a strong candidate for the Research for Best Researcher Award. Her work aligns well with the criteria typically used to evaluate research excellence, including innovation, impact, and contributions to advancing scientific knowledge.

Short Bio 🌟

Prof. Dr. MD. Ümmügülsüm Can is a distinguished biochemist currently serving in the Biochemistry Department at the University of Health Sciences / Konya City Hospital. With a strong background in biochemistry, her work emphasizes oxidative stress and metabolic disorders, particularly focusing on diabetes and cardiovascular diseases.

Profile

SCOPUS

Education 🎓

  • Doctorate: Selçuk University, Medical Faculty, Biochemistry Department (1993-1996)
    Thesis: “Investigation of Serum, Leukocyte, and Erythrocyte Lipid Peroxidation and Antioxidative Defence Systems in Type 1 Diabetes Mellitus”
    Advisor: Idris Mehmetoğlu
  • Graduate Education: Istanbul University, Cerrahpasa Medical Faculty (1982-1988)

Experience 🏥

  • University of Health Sciences / Konya City Hospital, Biochemistry Department (2011-present)
  • Selçuk University, Medical Faculty, Biochemistry Department (1993-1996)

Research Interests 🔬

Prof. Can’s research primarily revolves around oxidative stress, lipid metabolism, and the role of biomarkers in chronic diseases. Her recent studies focus on microRNAs, oxidative stress markers, and their implications in various metabolic and cardiovascular conditions.

Awards 🏆

Prof. Can has been recognized for her contributions to biochemistry and clinical research through numerous awards and honors, reflecting her significant impact on the field.

Publications 📚

  1. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus
  2. Effect of moderate alcohol intake on lipid peroxidation in plasma, erythrocyte and leukocyte and on some antioxidant enzymes
  3. The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease
  4. Assessment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis
  5. The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity
  6. Serum total oxidant/antioxidant status, ischemia-modified albumin and oxidized-low density lipoprotein levels in patients with vitamin D deficiency
    • Archives of Endocrinology and Metabolism, 59(4), 318-324 (2015)
    • Link to publication
    • Citations: 35
  7. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome
    • Metabolic Syndrome and Related Disorders, 13(6), 272-277 (2015)
    • Link to publication
    • Citations: 12
  8. Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease
    • Journal of the Chinese Medical Association, 78(12), 702-708 (2015)
    • Link to publication
    • Citations: 77
  9. Evaluation of oxidant/anti-oxidants status in patients with mild acute pancreatitis
  10. Macro-aspartate aminotransferase (AST): a case report

 

Regine SITRUK WARE | Endocrinology | Best Researcher Award

Dr. Regine SITRUK WARE | Endocrinology | Best Researcher Award

Dr.Regine SITRUK WARE, Population Council, United States

Dr. Regine Sitruk-Ware is a prominent researcher affiliated with the Population Council in the United States. She has made significant contributions to the fields of reproductive health and contraception, particularly in the development of innovative contraceptive technologies. Her work focuses on advancing women’s health through the introduction of safe and effective contraceptive methods. Sitruk-Ware’s research has been instrumental in shaping global reproductive health policies and practices, addressing critical issues such as family planning and women’s empowerment worldwide.

Profile

Scopus

Education🎓

Paris University, Medical School, France,M.D., 1975, Medicine (Silver Medal),Specialist, 1976, Internal Medicine,Specialist, 1981, Reproductive Endocrinology 

Experience🏫

Dr. RéGINE SITRUK-WARE currently serves as a Distinguished Scientist at the Population Council in New York, NY, where she has been pivotal in advancing reproductive health research and development. Her career spans roles in academia, industry, and international organizations, focusing on reproductive endocrinology and drug development.

Industry and International Roles 

Head of International Medical Affairs, Ciba-Geigy, Basle, Switzerland (1989-1995),Head of Research and Development, Theramex, Monaco (1995-1997),Head of Medicine, Research & Development, Exelgyn, Paris, France (1997-2000),Executive Director Research & Development, Population Council, New York, NY (2000-2010),Distinguished Scientist, Population Council, New York, NY (2010-present)

Skills

Dr. Sitrak-Ware’s expertise spans preclinical and clinical research, drug safety, and the development of reproductive health technologies. She has a strong background in leading multidisciplinary teams and managing international collaborations in the pharmaceutical and academic sectors.

Research Focus

Dr. Sitrak-Ware’s research focuses on:,Development of novel contraceptive technologies, including non-surgical permanent contraception.,Pharmacology and therapeutic potential of progestins, particularly in neuroprotection and myelin repair.,Non-oral delivery systems for hormonal therapies and contraceptives.

Publications

Dr. Sitrak-Ware has published extensively in peer-reviewed journals, contributing significant findings to the fields of reproductive endocrinology, contraceptive technologies, and pharmacology. Selected publications include:

  • Chen S, Kumar N, Mao Z, Sitruk-Ware R, Brinton RD. Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain. Menopause. 2018;25(10):1138-1151.
  • El-Etr M, Rame M, Boucher C, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions. Glia. 2015;63(1):104-117.
  • Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, et al. Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation. Contraception. 2019;99(6):323-328.
  • Brache V, Vieira CS, Plagianos M, et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. Contraception. 2021;104(4):327-336.